PMC:7242013 / 6066-6558
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 161 | 479-482 | Gene | denotes | HCC | Gene:619501 |
| 162 | 298-301 | Gene | denotes | HCC | Gene:619501 |
| 163 | 206-209 | Gene | denotes | HCC | Gene:619501 |
| 164 | 35-38 | Gene | denotes | HCC | Gene:619501 |
| 165 | 21-24 | Gene | denotes | HCC | Gene:619501 |
| 188 | 7-15 | Species | denotes | patients | Tax:9606 |
| 189 | 284-292 | Species | denotes | patients | Tax:9606 |
| 230 | 262-270 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 231 | 307-315 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 232 | 437-445 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T86 | 21-24 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T87 | 35-38 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T88 | 206-209 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T89 | 262-270 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T90 | 298-301 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T91 | 307-315 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T92 | 437-445 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T93 | 479-482 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T27 | 0-6 | Chemical | denotes | Manage | http://purl.obolibrary.org/obo/CHEBI_81767 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T80 | 0-112 | Sentence | denotes | Manage patients with HCC Continue HCC surveillance schedule for high‐risk subjects; 2‐month delay is acceptable |
| T81 | 113-192 | Sentence | denotes | Document discussion of risks and benefits of delaying surveillance with patient |
| T82 | 193-279 | Sentence | denotes | Proceed with HCC treatments as appropriate Continue therapy for non‐COVID‐19 patients |
| T83 | 280-421 | Sentence | denotes | For patients with HCC with COVID‐19, postpone elective transplant and resection surgery, withhold immunotherapy Maintain care per guidelines |
| T84 | 422-458 | Sentence | denotes | Admit early if COVID‐19 is diagnosed |
| T85 | 459-492 | Sentence | denotes | Consider postponing HCC therapies |